Eikon Therapeutics, Inc. Common Stock (EIKN)

• Market cap: $783M
• 1 day: -3.33%
• 5 days: -14.96%
• 1 month: -3.33%
• 3 months: -3.33%
• 6 months: -3.33%
• Year to date: -3.33%
• 1 year: -3.33%
• 5 years: -3.33%
• 10 years: -3.33%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates.